학술논문
An effective and chemotherapy-free strategy of all-trans retinoic acid and arsenic trioxide for acute promyelocytic leukemia in all risk groups (APL15 trial).
Document Type
Article
Author
Source
Blood Cancer Journal; Nov2022, Vol. 12 Issue 11, p1-8, 8p
Subject
Language
ISSN
20445385
Abstract
Copyright of Blood Cancer Journal is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)